Skip to main content
. 2017 May 22;50(2):495–505. doi: 10.4143/crt.2016.577

Fig. 1.

Fig. 1.

Summary of clinical and molecular characteristics. Stages, results of molecular study and clinical outcomes were summarized. ALK, anaplastic lymphoma kinase; ATRX, alpha thalassemia/mental retardation syndrome X-linked; TERT, telomerase reverse transcriptase; INSS, International Neuroblastoma Staging System.